User Profile
Select your user profile

CoaguChek®: The Point of Care coagulation monitoring solution from Roche

Your trusted companion for anticoagulation care from the hospital to patients' homes.


Coagulation self-testing can reduce visits to the clinic and improve time in the therapeutic range1-5

Since 1992, CoaguChek® by Roche Diagnostics, has led the way in Point of Care (POC) testing, developing innovative solutions in coagulation monitoring for both professionals and patients alike. As a market leader in POC International Normalized Ratio (INR) monitoring solutions, CoaguChek®, has played a vital role in anticoagulation therapy, particularly for patients on Vitamin K Antagonist (VKA) medications such as warfarin.

Patient Self Testing of INR has emerged as a resounding success story. Patients managed with POC testing achieve a higher time in therapeutic range and fewer values out of range compared with patients treated with usual care.1-3 This results in fewer treatment-related complications,4,5 fewer hospitalizations and emergency department visits,4,5 and improved patient satisfaction.6-8

Despite the advent of Direct Oral Anticoagulants (DOACs), which have become the preferred choice for many patients, there remains a crucial segment for whom DOACs are not suitable. For these patients, CoaguChek® continues to be the cost-effective and proven INR monitoring solution, ensuring reliable and personalized care.

An HCP is sitting in a clinic setting with a patient. Together they are observing the data on a CoaguChek INRange system.

CoaguChek® solutions for the Point of Care

Performed by healthcare professionals immediately at the patient's point of care. CoaguChek® offers reliable and easy-to-use solutions that provide immediate results, allowing treatment decisions to be made promptly.

Contact us

Do you have questions about our products or services? We’re here to help. Contact a Roche representative in your region.

Form Successfully Submitted!
Thank you for your submission!
text

References

  1. Harrison et al. (2015). Int J Pharm Pract. 23, 173-181.
  2. Okuyama et al. (2014). Circ J. 78, 1342-1348.
  3. Mearns et al. (2014). Thromb J., 12:14.
  4. Karlsson. (2016). BMJ Qual Improv Rep. 5, pii.w4421.
  5. Kong et al. (2008). Ann Hematol. 87, 905-910.
  6. Chan et al. (2006). Br J Clin Pharmacol. 62, 601-609.
  7. Thompson et al. (2009). Pharm Pract (Granada) 7, 213-217.
  8. Wurster & Doran. (2006). Dis Manag. 9, 201-209.